Dr. Amber Khan, MD
2222 Greenhouse Rd, Bldg 800, The Houston Rheumatology Center, Houston, TX 77084 • +1-616-555-3002
Medical Education: Accredited U.S. Medical School (Class of 2018)
What This Doctor Actually Performs: CMS Medicare Utilization & Houston Percentiles
NPI #1811108475 • CBSA 26420 • Rheumatology
CMS Medicare Part B utilization records credit Dr. Amber Khan (MD, NPI 1811108475) at 2222 Greenhouse Rd, Bldg 800, The Houston Rheumatology Center in Houston with 138,135 annual clinical services (99 beneficiaries), corresponding to a +0.86σ regional deviation and top-decile high-throughput specialist (91.18th percentile in Houston) with sub-specialty concentration in 32 Active CMS HCPCS Codes.
Procedural volume for Dr. Khan is led by HCPCS 99214 (Autoimmune Arthritis & Biologic/DMARD Safety Evaluation — 567 annual services, $46–$63 GPCI cash estimate), followed by CPT 20610 (Large Joint Synovial Arthrocentesis or Corticosteroid Injection, 259/yr) and CPT 96413 (Intravenous Biologic Infusion Therapy (First Hour), 185/yr).
Direct cash-pay transparency modeling sets Dr. Khan's baseline new-consult rate near $212.00 in Houston, TX (cash-pay accepted, hybrid in-clinic and telehealth video consults, 18-minute average reception wait).
Credentialed as an MD specialist with 8 years post-graduation experience since completing medical school at an LCME/COCA institution (2018), Dr. Khan coordinates 32 Active CMS HCPCS Codes workups from 2222 Greenhouse Rd, Bldg 800, The Houston Rheumatology Center (+1-616-555-3002).
Top 10% Rheumatology volume leader in Houston, TX
138,135 annual services across 99 beneficiaries
Standard deviations from TX Rheumatology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Autoimmune Arthritis & Biologic/DMARD Safety Evaluation | 567 | 91.18th | $46 – $63 |
| 20610 | Large Joint Synovial Arthrocentesis or Corticosteroid Injection | 259 | 94.18th | $36 – $51 |
| 96413 | Intravenous Biologic Infusion Therapy (First Hour) | 185 | 90.18th | $63 – $86 |
| 76881 | Complete Joint Synovitis High-Resolution Ultrasound | 123 | 94.18th | $48 – $65 |
| 99204 | New Patient Autoimmune & Rheumatology Diagnostic Workup | 99 | 89.18th | $63 – $86 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (32 HCPCS billing breadth) | 136,903 | 91.18th | $45 – $65 |
Are you Dr. Amber Khan? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Houston, TX:
<a href="https://dotmd.com/doctors/amber-khan-md-houston-tx-1811108475" title="Dr. Amber Khan, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1811108475.svg" alt="Dr. Amber Khan Rheumatology Badge" width="280" height="72" /></a>
Dr. Amber Khan, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Khan National Provider Identifier | NPI #1811108475 (MD) | CMS NPPES Registry (77084) |
| Dr. Khan Houston CMS Volume Rank | 91.18th Pct (138,135 CMS svcs; Z +0.864σ) | CMS Medicare Part B (TX Rheumatology) |
| Fair Cash-Pay New-Patient Benchmark | $212.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Houston, TX) |
| Waiting-Room Wait Time & Cash Friendliness | $212.00 avg paid • 18 min lobby wait | 20 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.84/5 Listening • 4.75/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Amber Khan
Other High-Volume Rheumatology Specialists in Houston, TX
Ranked strictly by CMS Medicare volumeDr. Khan Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Houston, TX.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Amber Khan community threads and patient logs by age, biological sex, dosage, and treatment duration.